FDA Approves Exact Sciences’ Non-Invasive Test for Colorectal Cancer Screening
The FDA approved Exact Sciences' Cologuard Plus test, a stool DNA test that enhances colorectal cancer and precancerous lesion detection.
The FDA approved Exact Sciences' Cologuard Plus test, a stool DNA test that enhances colorectal cancer and precancerous lesion detection.
Study findings suggest that GPS results can help guide clinical management in this patient population.